Table 1.

Trial outcomes

Primary outcome at 12 months post-study enrollment

Percentage achieving the following: 1) HIV viral load undetectable AND 2) TB sputum culture conversiona AND 3) Survival + Retention in Careb

Secondary outcomes at 12 months

1) 12 Month TB clinical outcome 2) TB sputum culture conversiona 3) Time to culture conversion 4) Permanent change in TB or ART regimen 5) HIV viral load undetectable 6) Retention in careb 7) All-cause mortality 8) Time to mortality 9) Barriers, enablers, and socio-behavioral pathways to adherence

^aSputum TB culture shows no growth for at least two consecutive months without subsequent positive TB culture

^bParticipating in TB clinic without missing two or more consecutive TB clinic appointments